FGF7 and hematologic disorder: Currently, a truncated form of recombinant KGF (palifermin, brand name Kepivance) has been approved for the treatment of severe oral mucositis in patients with hematologic malignancies who have been treated with high doses of chemotherapy and radiation prior to autologous blood progenitor cell transplantation [42].